Evoke Pharma
EVOK
$0.45
Share price
2.27%
Change (1 day)
-76.68%
Change (1 year)
Categories
P/S ratio for Evoke Pharma (EVOK)
P/S ratio as of May 2024 (TTM): 0.7364
According to Evoke Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.736399. At the end of 2023 the company had a P/S ratio of 0.6778.
P/S ratio history for Evoke Pharma from 2013 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.6778 | -81.02% |
| 2022 | 3.57 | -67.83% |
| 2021 | 11.1 | -99.62% |
| 2020 | > 1000 | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ANI Pharmaceuticals ANIP | 2.84 | 286.26% | 🇺🇸 USA |
 Amphastar Pharmaceuticals AMPH | 3.13 | 324.78% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | 3.52 | 378.35% | 🇺🇸 USA |
 Ironwood Pharmaceuticals
IRWD | 2.78 | 277.85% | 🇺🇸 USA |